Logo do repositório
 
Publicação

Once we have it, will we use it?

dc.contributor.authorNeumann-Böhme, Sebastian
dc.contributor.authorVarghese, Nirosha Elsem
dc.contributor.authorSabat, Iryna
dc.contributor.authorBarros, Pedro Pita
dc.contributor.authorBrouwer, Werner B F
dc.contributor.authorvan Exel, Job
dc.contributor.authorSchreyögg, Jonas
dc.contributor.authorStargardt, Tom
dc.contributor.institutionNOVA School of Business and Economics (NOVA SBE)
dc.contributor.pblSpringer Science Business Media
dc.date.accessioned2024-04-08T22:20:54Z
dc.date.available2024-04-08T22:20:54Z
dc.date.issued2020-09-01
dc.descriptionFunding text: European Union (EU) grant nr. 721402; Excellence Strategy by the German federal and state governments; University of Hamburg, Erasmus School of Health Policy Management; Nova School of Business and Economics Lisbon-Chair BPI | "Fundacao La Caixa" on Health Economics
dc.description.abstractWhile the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect against the disease COVID-19, policymakers should prepare for the next challenge: uptake of the vaccine among the public. Having a vaccine does not automatically imply it will be used. Compliance with the anti-H1N1 vaccine during the 2009 influenza pandemic, for instance, was low [1], and in the decade since, vaccination rates have remained an issue of concern [2] while vaccination hesitancy has become more prevalent, leading to increases in disease outbreaks in multiple countries [3]. It is, therefore, important to understand whether or not people are willing to be vaccinated against COVID-19, as this can have large consequences for the success a vaccination programme—with potentially large health and economic consequences. In this editorial, we provide some first insights into this willingness to be vaccinated, based on a multi-country European study [4], which hopefully result in more attention for this important issue.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent857459
dc.identifier.doi10.1007/s10198-020-01208-6
dc.identifier.issn1618-7598
dc.identifier.otherPURE: 18885716
dc.identifier.otherPURE UUID: 052cdf10-1fd4-41b4-805d-889210759bb0
dc.identifier.otherPubMed: 32591957
dc.identifier.otherPubMedCentral: PMC7317261
dc.identifier.otherORCID: /0000-0002-0881-4928/work/76784439
dc.identifier.otherWOS: 000543598100001
dc.identifier.otherScopus: 85087309916
dc.identifier.urihttp://hdl.handle.net/10362/165955
dc.identifier.urlhttps://www.scopus.com/pages/publications/85087309916
dc.language.isoeng
dc.peerreviewedyes
dc.subjectSDG 3 - Good Health and Well-being
dc.titleOnce we have it, will we use it?en
dc.title.subtitleA European survey on willingness to be vaccinated against COVID-19en
dc.typejournal article
degois.publication.firstPage977
degois.publication.issue7
degois.publication.lastPage982
degois.publication.titleEuropean Journal Of Health Economics
degois.publication.volume21
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
s10198-020-01208-6.pdf
Tamanho:
837.36 KB
Formato:
Adobe Portable Document Format